リピトール錠５ｍｇ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB01076 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 53 |
| 日本商品名（例） | アトルバスタチンカルシウム１０ｍｇ錠, アトルバスタチンカルシウム５ｍｇ口腔内崩壊錠, アトルバスタチンカルシウム５ｍｇ錠 |
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | hyperlipidemia, familial combined, LPL related | 99% | DL |
| 2 | cerebral infarction | 99% | DL |
| 3 | obsolete susceptibility to ischemic stroke | 99% | DL |
| 4 | hyperlipoproteinemia | 99% | DL |
| 5 | homozygous familial hypercholesterolemia | 99% | DL |
| 6 | obsolete familial combined hyperlipidemia | 99% | DL |
| 7 | familial hypercholesterolemia | 99% | DL |
| 8 | HIV infectious disease | 99% | DL |
| 9 | brain stem infarction | 99% | DL |
| 10 | cholesterol-ester transfer protein deficiency | 99% | DL |
| 11 | hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | 99% | DL |
| 12 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | 99% | DL |
| 13 | arteriosclerosis disorder | 98% | DL |
| 14 | hypoalphalipoproteinemia | 98% | DL |
| 15 | hypercholesterolemia, autosomal dominant | 98% | DL |
| 16 | feline acquired immunodeficiency syndrome | 98% | DL |
| 17 | simian immunodeficiency virus infection | 98% | DL |
| 18 | ABri amyloidosis | 98% | DL |
| 19 | fibroma of prostate | 98% | DL |
| 20 | cerebral artery occlusion | 98% | DL |
| 21 | cerebral arterial disease | 98% | DL |
| 22 | hyperlipidemia due to hepatic triglyceride lipase deficiency | 98% | DL |
| 23 | benign reproductive system neoplasm | 98% | DL |
| 24 | Brenner tumor | 98% | DL |
| 25 | benign prostate phyllodes tumor | 98% | DL |
| 26 | prostate cancer/brain cancer susceptibility | 98% | DL |
| 27 | generalized atherosclerosis | 98% | DL |
| 28 | cerebral atherosclerosis | 98% | DL |
| 29 | stroke disorder | 97% | DL |
| 30 | male reproductive organ cancer | 97% | DL |
| 31 | familial hyperlipidemia | 97% | DL |
| 32 | prostate leiomyoma | 97% | DL |
| 33 | hypolipoproteinemia (disease) | 97% | DL |
| 34 | hyperlipidemia | 97% | DL |
| 35 | MRI defined brain infarct | 97% | DL |
| 36 | coronary atherosclerosis | 96% | DL |
| 37 | prostate neoplasm | 96% | DL |
| 38 | cerebrovascular disorder | 95% | DL |
| 39 | cholesterol embolism | 94% | DL |
| 40 | intracerebral hemorrhage | 93% | DL |
| 41 | hyperalphalipoproteinemia | 93% | DL |
| 42 | duodenal obstruction | 93% | DL |
| 43 | female breast carcinoma | 92% | DL |
| 44 | cardiac tamponade | 91% | DL |
| 45 | ABeta amyloidosis | 91% | DL |
| 46 | coronary artery disease | 91% | DL |
| 47 | sitosterolemia | 91% | DL |
| 48 | glaucoma | 90% | DL |
| 49 | hypertriglyceridemia, familial | 90% | DL |
| 50 | familial chylomicronemia syndrome | 90% | DL |
（上位50件を表示。全53件の予測があります）
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。